novo retatrutide Transformation – NOVO-LELA – Revolutionary Approach to Weight Loss BETTER THAN RETATRUTIDE? NEW TRIPLE

Beyond their effects on insulin secretion, accumulating evidence demonstrates that GLP-1 RAs also enhance insulin sensitivity and reduce systemic insulin resistance

The downside is larger injection volumes and faster depletion of vial contents (since you are pulling more liquid per dose)

This next frontier of obesity drug development stems in large part from the work of Matthias Tschp and Richard DiMarchi

Common Side Effects: Nausea and stomach pain Constipation and diarrhea Vomiting Fatigue and headache Acid reflux and heartburn Healthcare providers note that approximately 48.6% of patients experience adverse effects during treatment

Hsieh 1989)